Do analysts rate COSM or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, COSM or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cosmos Health $65.27M 0.20 -$19.15M -$0.64 N/A Hong Kong Pharma Digital Technology $13.43M 0.34 -$1.14M N/A N/A

Do analysts rate WGRX or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, WGRX or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $23.34M 0.37 -$101.28M -$44.50 N/A Hong Kong Pharma Digital Technology $13.43M 0.34 -$1.14M N/A N/A

Is WGRX or HKPD more profitable?

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -545.69%. Company Net Margins Return on Equity Return on Assets Wellgistics Health -545.69% N/A -145.69% Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts recommend HKPD or RDGT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, HKPD or RDGT?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.34 -$1.14M N/A N/A Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Is HKPD or RDGT more profitable?

Company Net Margins Return on Equity Return on Assets Hong Kong Pharma Digital Technology N/A N/A N/A Ridgetech N/A N/A N/A

Do analysts prefer HKPD or MCK?

McKesson has a consensus price target of $977.00, indicating a potential upside of 12.46%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 McKesson 0 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.82

Which has preferable earnings & valuation, HKPD or MCK?

McKesson has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.34 -$1.14M N/A N/A McKesson $403.43B 0.25 $4.76B $37.37 23.25

Do analysts prefer HKPD or COR?

Cencora has a consensus target price of $374.25, suggesting a potential upside of 19.24%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cencora 0 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.87

Which has higher earnings & valuation, HKPD or COR?

Cencora has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.34 -$1.14M N/A N/A Cencora $321.33B 0.19 $1.55B $13.46 23.32

Hong Kong Pharma Digital Technology (HKPD) Competitors

$0.42 0.00 (-0.02%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$0.40 -0.02 (-4.50%)

As of 08/14/2026 05:03 PM Eastern

Compare

HKPD vs. COSM, WGRX, RDGT, MCK, and COR

Should you buy Hong Kong Pharma Digital Technology stock or one of its competitors? Hong Kong Pharma Digital Technology's main competitors and comparable companies include Cosmos Health (COSM), Wellgistics Health (WGRX), Ridgetech (RDGT), McKesson (MCK), and Cencora (COR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Cosmos Health (NASDAQ:COSM) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, Hong Kong Pharma Digital Technology had 1 more articles in the media than Cosmos Health. MarketBeat recorded 2 mentions for Hong Kong Pharma Digital Technology and 1 mentions for Cosmos Health. Cosmos Health's average media sentiment score of 1.89 beat Hong Kong Pharma Digital Technology's score of 0.75 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Overall Sentiment
Cosmos Health	Very Positive
Hong Kong Pharma Digital Technology	Positive

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -30.41%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-30.41%	-52.85%	-17.87%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

12.6% of Cosmos Health shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.20	-$19.15M	-$0.64	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.34	-$1.14M	N/A	N/A

Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.33, suggesting that its stock price is 133% more volatile than the broader market.

Summary

Hong Kong Pharma Digital Technology beats Cosmos Health on 6 of the 11 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Wellgistics Health (NASDAQ:WGRX) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

In the previous week, Hong Kong Pharma Digital Technology had 2 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for Hong Kong Pharma Digital Technology and 0 mentions for Wellgistics Health. Hong Kong Pharma Digital Technology's average media sentiment score of 0.75 beat Wellgistics Health's score of 0.00 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Wellgistics Health	Neutral
Hong Kong Pharma Digital Technology	Positive

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.37	-$101.28M	-$44.50	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.34	-$1.14M	N/A	N/A

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -545.69%.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-545.69%	N/A	-145.69%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Wellgistics Health has a beta of -1.47, meaning that its share price is 247% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Hong Kong Pharma Digital Technology beats Wellgistics Health on 6 of the 8 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Hong Kong Pharma Digital Technology has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, meaning that its share price is 113% less volatile than the broader market.

45.3% of Ridgetech shares are held by institutional investors. 22.6% of Ridgetech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Ridgetech had 7 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 9 mentions for Ridgetech and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 0.75 beat Ridgetech's score of 0.21 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Positive
Ridgetech	Neutral

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.34	-$1.14M	N/A	N/A
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Ridgetech	N/A	N/A	N/A

Summary

Hong Kong Pharma Digital Technology and Ridgetech tied by winning 4 of the 8 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to McKesson?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

85.1% of McKesson shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

McKesson has a net margin of 1.12% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
McKesson	1.12%	-253.21%	5.90%

McKesson has a consensus price target of $977.00, indicating a potential upside of 12.46%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

Hong Kong Pharma Digital Technology has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market. Comparatively, McKesson has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

In the previous week, McKesson had 20 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 22 mentions for McKesson and 2 mentions for Hong Kong Pharma Digital Technology. McKesson's average media sentiment score of 0.88 beat Hong Kong Pharma Digital Technology's score of 0.75 indicating that McKesson is being referred to more favorably in the news media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Positive
McKesson	Positive

McKesson has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.34	-$1.14M	N/A	N/A
McKesson	$403.43B	0.25	$4.76B	$37.37	23.25

Summary

McKesson beats Hong Kong Pharma Digital Technology on 11 of the 14 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Cencora?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cencora (NYSE:COR) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

97.5% of Cencora shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Hong Kong Pharma Digital Technology has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market. Comparatively, Cencora has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market.

Cencora has a consensus target price of $374.25, suggesting a potential upside of 19.24%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cencora	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.87

Cencora has a net margin of 0.79% compared to Hong Kong Pharma Digital Technology's net margin of 0.00%. Cencora's return on equity of 125.45% beat Hong Kong Pharma Digital Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Cencora	0.79%	125.45%	4.18%

Cencora has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.34	-$1.14M	N/A	N/A
Cencora	$321.33B	0.19	$1.55B	$13.46	23.32

In the previous week, Cencora had 21 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 23 mentions for Cencora and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 0.75 beat Cencora's score of 0.72 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Positive
Cencora	Positive

Summary

Cencora beats Hong Kong Pharma Digital Technology on 11 of the 14 factors compared between the two stocks.

Get Hong Kong Pharma Digital Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HKPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HKPD vs. The Competition

Export

Metric	Hong Kong Pharma Digital Technology	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.62M	$9.80B	$7.06B	$13.10B
Dividend Yield	N/A	2.55%	2.57%	10.45%
P/E Ratio	N/A	35.17	269.06	25.28
Price / Sales	0.34	4.78	601.61	91.31
Price / Cash	N/A	124.34	70.48	50.90
Price / Book	0.93	3.94	12.91	6.24
Net Income	-$1.14M	$309.96M	$3.45B	$347.60M
7 Day Performance	-0.02%	0.10%	1.10%	1.06%
1 Month Performance	-7.51%	-0.32%	1.32%	0.81%
1 Year Performance	-60.57%	19.53%	62.43%	20.90%

Hong Kong Pharma Digital Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HKPD Hong Kong Pharma Digital Technology	0.6226 of 5 stars	$0.42 0.0%	N/A	-60.4%	$4.62M	$13.43M	N/A	19	Earnings Report Analyst Downgrade Short Interest Increase
COSM Cosmos Health	2.7406 of 5 stars	$0.22 flat	N/A	-75.4%	$12.95M	$65.27M	N/A	100	Positive News Upcoming Earnings
WGRX Wellgistics Health	0.2639 of 5 stars	$3.46 -1.7%	N/A	-89.6%	$8.69M	$23.34M	N/A	31	Gap Down High Trading Volume
RDGT Ridgetech	0.9097 of 5 stars	$0.76 flat	N/A	-99.6%	$680K	$132.16M	N/A	980	Gap Up
MCK McKesson	4.9073 of 5 stars	$857.61 +0.2%	$962.67 +12.3%	+28.8%	$100.41B	$403.43B	22.29	43,000	Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HKPD) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. COSM, WGRX, RDGT, MCK, and COR

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Summary

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Summary

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Summary

How does Hong Kong Pharma Digital Technology compare to McKesson?

Summary

How does Hong Kong Pharma Digital Technology compare to Cencora?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. COSM, WGRX, RDGT, MCK, and COR

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Does the media prefer COSM or HKPD?

Is COSM or HKPD more profitable?

Do analysts rate COSM or HKPD?

Do institutionals and insiders hold more shares of COSM or HKPD?

Which has better valuation & earnings, COSM or HKPD?

Which has more volatility & risk, COSM or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to Wellgistics Health?

Does the media favor WGRX or HKPD?

Which has higher valuation & earnings, WGRX or HKPD?

Is WGRX or HKPD more profitable?

Which has more risk & volatility, WGRX or HKPD?

Do analysts rate WGRX or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to Ridgetech?

Which has more risk & volatility, HKPD or RDGT?

Do institutionals and insiders hold more shares of HKPD or RDGT?

Does the media favor HKPD or RDGT?

Which has preferable valuation and earnings, HKPD or RDGT?

Do analysts recommend HKPD or RDGT?

Is HKPD or RDGT more profitable?

Summary

How does Hong Kong Pharma Digital Technology compare to McKesson?

Do institutionals and insiders have more ownership in HKPD or MCK?

Is HKPD or MCK more profitable?

Do analysts prefer HKPD or MCK?

Which has more volatility and risk, HKPD or MCK?

Does the media favor HKPD or MCK?

Which has preferable earnings & valuation, HKPD or MCK?

Summary

How does Hong Kong Pharma Digital Technology compare to Cencora?

Do insiders and institutionals have more ownership in HKPD or COR?

Which has more volatility and risk, HKPD or COR?

Do analysts prefer HKPD or COR?

Is HKPD or COR more profitable?

Which has higher earnings & valuation, HKPD or COR?

Does the media favor HKPD or COR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools